# Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment

> **NCT01508494** · PHASE2 · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 47 (actual)

## Conditions studied

- Stroke
- Cognitive Impairment

## Interventions

- **DRUG:** Galantamine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01508494
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-29
- **Primary completion:** 2016-06
- **Final completion:** 2016-06-22
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01508494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01508494, "Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01508494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*